choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Anthera Pharmaceuticals IPO

Anthera Pharmaceuticals IPO Newsletter
  • Visterra IPO: Hold Off For Now 25 Jan 2017 13:19 GMT

    … previewed this deal on our IPO Insights platform. Visterra will … the underwriters price the IPO at the midpoint of that … Sciences, Sanofi (NYSE:SNY), Anthera Pharmaceuticals (NASDAQ:ANTH) and Merck (NYSE … and analysis on the major IPOs each week, along with …

  • Visterra Seeks $50 Million IPO 23 Jan 2017 21:49 GMT

    … is to BUY the IPO. Company Cambridge, Massachusetts … (NYSE:GSK) Theraclone Sciences Anthera Pharmaceuticals (NASDAQ:ANTH) Merck Financials … option. Assuming a successful IPO, total common stock … IPO at up to $14 per share. I write about technology IPOs …

  • Tentarix Biotherapeutics Announces the Strengthening of its Leadership and Advisory Teams 20 May 2022 13:08 GMT

    … audit and compensation committees of Anthera Pharmaceuticals, Inc. and as a director … initiatives, including the company’s initial public offering and important pre-clinical and …

  • Versartis - Preparing To Get A Lot Bigger, Very Soon 07 Aug 2017 15:02 GMT

    … joined Versartis in 2016 from Anthera Pharmaceuticals, where he was a … founding member of Anthera’s management team and … Chief Medical Officer. Before joining Anthera, Dr. Hislop was Vice … ’s successful $105 million initial public offering. Also at ZELTIQ as …

  • Global Oral Proteins and Peptides Market to 2030 16 Aug 2018 12:25 GMT

    … financing, grants, capital raised from IPOs and subsequent offerings. A publication … ) 9.4. Sollpura / Liprotamase (Anthera Pharmaceuticals) 10. ORAL DRUG DELIVERY TECHNOLOGY … .1. Chapter Overview 20.2. Anthera Pharmaceuticals 20.3. Carmot Therapeutics 20 …

Satisfied with the content?

Continue to create your account.